Window of Opportunity Study of DSP-0390 in Gliomas

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Glioma, Malignant · IDH Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Omar H Butt, M.D., Ph.D.) · omarhbutt@wustl.edu · 314-747-4241
Contact: Principal Investigator (Omar H Butt, M.D., Ph.D.)
Ryan Cleary, M.D. (Sub-investigator)
Albert H Kim, M.D., Ph.D. (Sub-investigator)
Jingqin (Rosy) Luo, Ph.D. (Sub-investigator)

Study leads

Omar H Butt, M.D., Ph.D.
Principal Investigator
Washington University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Malignant Glioma of Brain · Astrocytoma · Malignant Astrocytoma

Abroad (travel likely)RecruitingPHASE1

Detroit, United States

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Glioblastoma Multiforme · Glioma, Malignant

Abroad (travel likely)RecruitingPHASE1

Beijing, China

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Recurrent Glioblastoma · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Relapsed Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Glioma · Glioblastoma Multiforme

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rochester, United States · Omaha, United States